A Toronto man living with HIV has achieved undetectable viral levels following a bone marrow transplant, a development that doctors are calling a significant milestone in HIV research. The patient, who has not been publicly identified, underwent the procedure at Toronto General Hospital as part of a treatment for blood cancer. Dr. Sharon Walmsley, HIV Clinic Director at the University Health Network's Toronto General Hospital and Speck Family Chair in Emerging Infectious Diseases, announced the news on April 25, 2026.
Details of the Case
The bone marrow transplant was performed to treat the man's leukemia, but it also appears to have eliminated detectable HIV from his body. This marks the first such case in Canada and one of only a handful worldwide. Dr. Walmsley emphasized that while the patient is now in remission for both cancer and HIV, it is too early to declare a definitive cure. The man will continue to be monitored closely.
Implications for HIV Research
This case adds to a growing body of evidence that bone marrow transplants from donors with a rare genetic mutation, known as CCR5-delta32, can potentially eradicate HIV. The mutation prevents HIV from entering cells. However, such transplants are high-risk and not suitable for most people with HIV. Researchers stress that this approach is reserved for patients who also need a transplant for life-threatening blood cancers.
Dr. Walmsley noted that this breakthrough provides hope and valuable insights for developing more widely applicable treatments. The team plans to publish the full findings in a peer-reviewed journal to contribute to global efforts to find an HIV cure.
Patient's Journey
The patient, a resident of the Greater Toronto Area, was diagnosed with HIV several years ago and later developed acute myeloid leukemia. After standard treatments failed, he was considered for a bone marrow transplant. The donor was identified through international registries and carried the CCR5-delta32 mutation. The transplant occurred in 2025, and subsequent tests have shown no detectable HIV RNA in the patient's blood.
The man is reportedly in good spirits and has expressed gratitude to the medical team and donor. He hopes his case will inspire continued research and reduce stigma around HIV.
Expert Reactions
HIV specialists worldwide have reacted with cautious optimism. Dr. Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases, called the case 'encouraging' but reiterated that bone marrow transplants are not a practical solution for the millions living with HIV globally. Canadian health officials have praised the work of Dr. Walmsley and her team, highlighting the importance of ongoing investment in HIV cure research.
The announcement comes amid World AIDS Day preparations and underscores progress since the first reported HIV cure in 2007 with the 'Berlin patient.'
